申请人:Pfizer Inc
公开号:US20040063940A1
公开(公告)日:2004-04-01
The present invention relates to compounds of the formula I,
1
wherein Z
1
, Z
2
, X, Q, R
1
, R
2
and R
3
are defined as in the specification, pharmaceutical compositions containing such compounds the use of such compounds to treat neurological and gastrointestinal disorders.
本发明涉及公式I的化合物,其中Z1,Z2,X,Q,R1,R2和R3如规范中所定义,含有这种化合物的制药组合物以及使用这种化合物治疗神经和胃肠障碍的方法。